Will gene editing lead to a treatment for Huntington's disease?
Cardiff University researchers have used a CRISPR-based approach to shorten the harmful DNA repeats behind Huntington's disease in mice. It's early-stage work, but it targets the root cause rather than the symptoms. Is this a real step towards a treatment, or still a long way off for patients?